SCHEMBL2209201

SCHEMBL2209201

Cc1cc(OCc2ccccc2)cc(C)c1CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP1A2 P05177 2/20 0.50
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
LTA4H P09960 1/20 0.50
EPHX2 P34913 1/20 0.50
LMNA P02545 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAOB P27338 6/20 0.49
MRGPRX4 Q96LA9 1/20 0.48
ALOX5 P09917 1/20 0.47
RRM1 P23921 1/20 0.47
GSTP1 P09211 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4509863 0.91 MEN1 (0.46) MEN1KMT2ACYP1A2CYP4F2CYP4A11
SCHEMBL24132796 0.89 MRGPRX4 (0.49) MEN1KMT2ACYP1A2CYP4F2CYP4A11
SCHEMBL20781419 0.83 MAOB (0.54) MEN1KMT2ACYP1A2LMNAPTGS1
SCHEMBL2203344 0.83 MAOB (0.49) MEN1KMT2ACYP1A2LMNAPTGS1
SCHEMBL10030221 0.82 CYP1A2 (0.58) MEN1KMT2ACYP1A2CYP4F2CYP4A11
SCHEMBL9780596 0.82 MEN1 (0.55) MEN1KMT2AMAOBMRGPRX4ALOX5
SCHEMBL10903897 0.82 L3MBTL1 (0.55) MEN1KMT2ACYP1A2LMNAPTGS1
SCHEMBL26047480 0.82 MAOB (0.49) MAOB
SCHEMBL1143540 0.80 MAOB (0.53) MEN1KMT2ACYP1A2LMNAPTGS1
SCHEMBL10477402 0.80 APP (0.53) MEN1KMT2ACYP1A2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029579-B1 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2014-12-31 EP disclosed
CN-101426783-B Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 LILLY CO ELI 2013-10-30 CN disclosed
US-7981918-B2 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2011-07-19 US disclosed
CN-101426783-A Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 LILLY CO ELI (US) 2009-05-06 CN disclosed
US-20090111800-A1 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-04-30 US disclosed
EP-2029579-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-03-04 EP disclosed
WO-2007124254-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111800-A1 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD3B1, HSD17B1 MEN1 2040/4885KMT2A 2646/4885CYP1A2 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.